Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP675453.RADOqV7_sL_FydkebOaVbT2FUh6wMwpz5kmPnp2GzY1Tg130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675453.RADOqV7_sL_FydkebOaVbT2FUh6wMwpz5kmPnp2GzY1Tg130_provenance.
• NP992627.RAXt-ciEcW8zmonwyytm0xHH2pq-RzFOzPLRu7OvUMHyA130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992627.RAXt-ciEcW8zmonwyytm0xHH2pq-RzFOzPLRu7OvUMHyA130_provenance.
• NP995358.RA6FIoutFMSguBwTPTl7PIXjuIiuaydudKN4T4Og6Rvjg130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995358.RA6FIoutFMSguBwTPTl7PIXjuIiuaydudKN4T4Og6Rvjg130_provenance.
• NP994181.RAQflk4DlSuZlh5huCmKEDEroYxWYw1Jjc2Z_srGrAZXE130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994181.RAQflk4DlSuZlh5huCmKEDEroYxWYw1Jjc2Z_srGrAZXE130_provenance.
• NP994224.RAfAWP3lTPzj4A65KnY1GuHrD7dAl7wCnt-6uwRDT7t3A130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994224.RAfAWP3lTPzj4A65KnY1GuHrD7dAl7wCnt-6uwRDT7t3A130_provenance.
• NP995280.RAabNlkycQuBOvWCY1iUluZQBosdvmwupUbC4ob48oUyU130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995280.RAabNlkycQuBOvWCY1iUluZQBosdvmwupUbC4ob48oUyU130_provenance.
• NP675443.RA4rNcUt-LuTxycdXHix6mZL5S8YodYt3sDIBiPG01M9g130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675443.RA4rNcUt-LuTxycdXHix6mZL5S8YodYt3sDIBiPG01M9g130_provenance.
• NP675451.RA3qSAh5AIJIx7YsnltcbV7C3tDyOPSkJv0-wy6XWgHqQ130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675451.RA3qSAh5AIJIx7YsnltcbV7C3tDyOPSkJv0-wy6XWgHqQ130_provenance.
• NP675444.RAaRLEeDWg4R30TAeZkQ-K1jhwGEHUE9LDn_N4M9cgf3U130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675444.RAaRLEeDWg4R30TAeZkQ-K1jhwGEHUE9LDn_N4M9cgf3U130_provenance.
• NP675458.RAbEScbHnOlaFOtTBR1VzoM3Bq_hLIyFPejieVnCNX9gY130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675458.RAbEScbHnOlaFOtTBR1VzoM3Bq_hLIyFPejieVnCNX9gY130_provenance.
• assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP995697.RAgXrZV9jI5e3w5ikAKA8-z-Ut4ipuILpkMN_2nJ5BIA4130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995697.RAgXrZV9jI5e3w5ikAKA8-z-Ut4ipuILpkMN_2nJ5BIA4130_provenance.
• NP994984.RAHkNqSCI8uyIS3fauFyJu9xY2Ge6_KEdc1RHBH7z6_7k130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994984.RAHkNqSCI8uyIS3fauFyJu9xY2Ge6_KEdc1RHBH7z6_7k130_provenance.
• NP995004.RAPRanSgeoEBQCpMceE8crjdibscyfgbLc-kNkN7Um_JM130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995004.RAPRanSgeoEBQCpMceE8crjdibscyfgbLc-kNkN7Um_JM130_provenance.
• NP998108.RAJtYu64ekRBgoJwRne83GnxcGbCD40_xFVKL46URgv4c130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998108.RAJtYu64ekRBgoJwRne83GnxcGbCD40_xFVKL46URgv4c130_provenance.
• assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP675446.RAPYvwwL5BZgbgCj3S9aAFONcnJE8T7laOCjCzNoA-rF0130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675446.RAPYvwwL5BZgbgCj3S9aAFONcnJE8T7laOCjCzNoA-rF0130_provenance.
• NP675449.RAEfCj0q9ZfzoiWo-rIVcb44f7OwRjwVieJM105Qf1dWQ130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675449.RAEfCj0q9ZfzoiWo-rIVcb44f7OwRjwVieJM105Qf1dWQ130_provenance.
• NP675452.RAEJcjKlhrKdKDK1j7rnjM5UPzeV4ehAexmuSUCjafu50130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675452.RAEJcjKlhrKdKDK1j7rnjM5UPzeV4ehAexmuSUCjafu50130_provenance.
• NP675448.RAh_4V-ICiA43F_I768zWszzNo6D5Vg2LNQMRqIsZi3h4130_assertion description "[Comparison of the possible combinations of DLBCL-, FL- and LN resulted in specific DLBCL- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or tumour development (MIRN210, MIRN10A, MIRN17-5P and MIRN145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675448.RAh_4V-ICiA43F_I768zWszzNo6D5Vg2LNQMRqIsZi3h4130_provenance.